Delivery Order SPE2DB22D3016-SPE2DB24FAQD3

Award Date 3/17/24
Potential Completion Date 3/18/24
Potential Value $9.9K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,563,756,328 units of the drug Droxidopa 100 mg capsules, which are used for the treatment of certain medical conditions. The contract has a firm fixed price of $23,689.00 and a completion date of February 26, 2024. The contract is not set aside for any specific business type....
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp's Corporate Office division to provide 90-count bottles of 300 mg Droxidopa capsules. The $17,658.57 contract has an ultimate completion date of August 19, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for a wide range of...
This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the provision of 4,566,148,800 units of the medication droxidopa 300 mg capsules. The contract has a firm fixed price of $5,122.05 and a period of performance through October 21, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a $13,920.91 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 90-count packages of the drug DROXIDOPA 100 MG CAPSULE. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and AmerisourceBergen, which provides a comprehensive range of pharmaceutical products and medical supplies to support military...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,721.40 firm fixed price delivery order contract is for the supply of DROXIDOPA 100 MG CAPSULE 90S, a pharmaceutical product, with a period of performance through February 26, 2025. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
The U.S. Defense Logistics Agency (DLA) awarded a $3,239.99 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, Corporate Office Division, to provide 4566054689 DROXIDOPA 200 MG CAPSULE 90S. This contract has an ultimate completion date of October 9, 2024 and is not set aside for a specific socioeconomic program. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies,...
The Defense Logistics Agency awarded a $12,140.28 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 100 mg capsules of droxidopa, a pharmaceutical used to treat neurological conditions. Amerisourcebergen will deliver 90 capsules of the drug to a location in Conshohocken, Pennsylvania by August 9, 2023 in fulfillment of the order. As a major supplier of pharmaceuticals and medical supplies to the Department of Defense, Amerisourcebergen routinely supports the Defense...
The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, for the provision of 120-count VONJO 100 MG capsules. The $13,262.28 contract has a completion date of March 19, 2024 and was awarded on February 27, 2024. This delivery order is placed under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00 through...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract worth $1,771.94 to Amerisourcebergen Drug Corp, a subsidiary of the for-profit Amerisourcebergen Corporation. The contract is for the delivery of a pharmaceutical product, DOPAMINE 400 MG/250 ML-D5W BAG 250ML, with a completion date of February 6, 2024. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA as the prime contractor, with a potential value of $999,999,999.00 and a...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order worth $1,591.20 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical distributor. The order is for norepinephrine 4ML 10s, a specialty pharmaceutical product. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of $999,999,999.00 and a...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB24FAQD3
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of 4,563,988,174 units of the pharmaceutical drug Droxidopa 100 mg capsule. The contract has a ceiling value of $9,909.13 and a period of performance through March 18, 2024. This delivery order is issued under an indefinite delivery contract (IDC) awarded solely to AmerisourceBergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.

Generated 6/16/24, 9:14 AM